Abstract
Background: More than 90% of cancer deaths are caused by cancer metastasis. Cancer metastatic therapy is a top priority topic.
Objective: New therapeutics against cancer metastasis is to be discovered.
Methods: In the past pathogenesis study, a therapeutic dilemma has been discovered from literatures of epithelial-mesenchymal cell interchange in late-staged cancer patients—opposite tumor pathogenesis routes between primary and metastatic tumors.
Results: Possible options for overcoming this dilemma are enlisted from different therapeutic attempts (such as novel drug target (cancer biomarkers) discovery, antimetastatic drug developments, biotherapies, drug combinations, cancer therapeutics according to metastatic cascades, different types of personalized medicine paradigms and so on).
Conclusions: These therapeutic options might change the landscape of cancer treatments and managements in clinics forever.
Keywords: Neoplasm metastases, cancer chemotherapy, personalized cancer therapy, drug sensitivity testing, drug combination, pharmacogenetics, personalized medicine.
Current Drug Therapy
Title:Cancer Metastasis, a Clinical Dilemma for Therapeutics
Volume: 11 Issue: 2
Author(s): Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Rong-Xin Qi, Nagendra S. Yarla, Xiao-Die Zhou and Jian Ding
Affiliation:
- Shanghai University, Shanghai 200444, P.R. China.,China
Keywords: Neoplasm metastases, cancer chemotherapy, personalized cancer therapy, drug sensitivity testing, drug combination, pharmacogenetics, personalized medicine.
Abstract: Background: More than 90% of cancer deaths are caused by cancer metastasis. Cancer metastatic therapy is a top priority topic.
Objective: New therapeutics against cancer metastasis is to be discovered.
Methods: In the past pathogenesis study, a therapeutic dilemma has been discovered from literatures of epithelial-mesenchymal cell interchange in late-staged cancer patients—opposite tumor pathogenesis routes between primary and metastatic tumors.
Results: Possible options for overcoming this dilemma are enlisted from different therapeutic attempts (such as novel drug target (cancer biomarkers) discovery, antimetastatic drug developments, biotherapies, drug combinations, cancer therapeutics according to metastatic cascades, different types of personalized medicine paradigms and so on).
Conclusions: These therapeutic options might change the landscape of cancer treatments and managements in clinics forever.
Export Options
About this article
Cite this article as:
Lu Da-Yong*, Lu Ting-Ren, Xu Bin, Qi Rong-Xin, Yarla S. Nagendra, Zhou Xiao-Die and Ding Jian, Cancer Metastasis, a Clinical Dilemma for Therapeutics, Current Drug Therapy 2016; 11 (2) . https://dx.doi.org/10.2174/1574885511666160810143216
DOI https://dx.doi.org/10.2174/1574885511666160810143216 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling
Current Pharmaceutical Design Heat Shock Protein Inhibitors for the Treatment of Fungal Infections
Recent Patents on Anti-Infective Drug Discovery Biotransformations of Prenylated Hop Flavonoids for Drug Discovery and Production
Current Drug Metabolism Medicinal Plants from Peru: A Review of Plants as Potential Agents Against Cancer
Anti-Cancer Agents in Medicinal Chemistry New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer
Current Pharmaceutical Design The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma
Current Pediatric Reviews Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
Current Medicinal Chemistry Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine Pure Red Cell Aplasia Caused by Azathioprine
Cardiovascular & Hematological Disorders-Drug Targets Microarrays and Colon Cancer in the Road for Translational Medicine
Current Bioinformatics Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry The ALK Gene, An Attractive Target for Inhibitor Development
Current Topics in Medicinal Chemistry A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies
Current Pharmaceutical Design Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis
Current Signal Transduction Therapy Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics Gene Therapy in the Transplantation of Allogeneic Organs and Stem Cells
Current Gene Therapy Editorial (Another Year of Prosperity for Current Molecular Medicine)
Current Molecular Medicine